Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

• Status: Completed
• Trial end date: 2012-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To collect the efficacy and safety informations of voriconazole related to their appropriate use in daily practice.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Voriconazole

Criteria

Inclusion Criteria:

• Male or Female subjects intend to treat their deep mycosis who are prescribed voriconazole (VFEND) by their Physicians.

Exclusion Criteria:

• Subject who heve been prescribed voriconazole (VFEND) before.